TAKEDA PHARMACEUTICALS U.S.A, INC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for TAKEDA PHARMACEUTICALS U.S.A, INC.

Sort by

Viewing results 1‒25 of 1607

Equities
Pandemic-era winners suffer $1.5tn fall in market value
...According to data from S&P Global, technology groups dominate the list of the 50 companies with a market value of more than $10bn that made the biggest percentage gains in 2020....
May 8, 2024
News in-depthWeight Watchers International Inc
WeightWatchers faces an era when weight loss comes in a syringe
...Two weeks after losing its most prominent brand ambassador, the weight-loss group lost another fifth of its value on reports its lenders were preparing for debt talks after S&P cut its credit rating to a...
April 9, 2024
FT Live
FTWeekend Festival: U.S. edition
The Saturday where the Financial Times Weekend paper comes to life
Saturday, 10 May 2025The REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
High yield bonds
Is it PIK-up time for cash-strapped companies?
...Sure, a CCC-rated PIK bond looks better than a defaulted bond in your portfolio. But, as S&P puts it when explaining why U.S....
February 21, 2024
Investments
Behold, the Basquiat bond
...ArtFi 2024-1’s prospectus has further detail on the collateral backing the deal, which it notes can include “fine art, collectibles, design furniture, coins, books, jewelry, watches, wine or other spirits...
April 12, 2024
Skechers USA Inc
Skechers’ family troubles
...In last night from the SEC: The Securities and Exchange Commission today [Thursday] announced that Skechers U.S.A....
March 8, 2024
Energy Source
Oil and gas executives expect slower transition to net zero Premium content
...The slower expectations for the transition come as companies make U-turns on their climate pledges and governments double down on fossil fuels amid energy security concerns....
March 14, 2024
FT Live
Managing Operational Risk in M&A Transactions
Examining the value of business licensing and property tax in the deal cycle
Thursday, 20 JuneDigital Conference
Investing in funds
Back into the active/passive trenches
...Here’s a chart looking at the waning outperformance of all 39 different categories that S&P DJI tracks — across both equities and fixed income....
September 21, 2023
ESG investing
S&P drops ESG scores from debt ratings amid scrutiny
...The U-turn puts S&P at odds with debt rating rival Moody’s, which still rates ESG criteria on a one to five scale. S&P is influential, with debt ratings that can affect a company’s borrowing cost....
August 8, 2023
Scoreboard
Hollywood comes for Formula One Premium content
...The price has been pushed up by F1’s booming popularity in the US, and also the sport’s new spending caps that have put a lid on costs....
July 1, 2023
LexMerck & Co Inc
Merck/Prometheus: Big Pharma must swallow bigger premiums Premium content
...The New Jersey pharmaceutical titan’s share price has doubled in the past five years, well ahead of the wider S&P 500 index....
April 17, 2023
Sovereign bonds
PSA: no one should care about the US credit rating
...(when the U.S....
May 25, 2023
Walgreens Boots Alliance Inc
Walgreens Boots chief steps down after latest profit forecast downgrade
...Ginger Graham, a board member since 2010 and former chief of Amylin Pharmaceuticals, will fill the chief executive role while it searches for “a successor with deep healthcare experience”....
September 1, 2023
Energy sector
Bets on energy transition spark rise in North American pipeline deals
...An investor opposed to the deal, Energy Income Partners, pointed out that this position was a U-turn from a bullish management outlook offered as recently as 2022....
September 23, 2023
Pfizer Inc
Pfizer to start selling stake in Advil maker Haleon within months, says CFO
...Pfizer said its acquisition of Seagen — the largest pharmaceutical deal agreed since 2019 — would contribute more than $10bn in 2030 risk-adjusted revenues, with potential significant growth beyond 2030....
May 2, 2023
Pfizer Inc
Pfizer gears up to make Covid drug Paxlovid in China
...He added negotiations with the state health insurer aimed at agreeing a further price reduction from April 1 had not reached a conclusion....
January 10, 2023
FT Live
Decarbonising India's Industries
Unlocking the technologies and capital required to accelerate progress
Tuesday, 11 JuneDigital Conference
LexJohnson & Johnson Co Inc
J&J/Kenvue: IPO will test investor appetite Premium content
...A successful listing would focus J&J on its pharmaceutical and medical-device business. The company is just one of a number of legacy US giants engaged in streamlining....
January 5, 2023
Digital currencies
The Crypt, updated
...s=46&t=uS_p1jt3N5TYYYWqkDeEiw Also 15 November 2022: “Bnk To The Future (the ‘Company’) announces that its previously announced non-binding letter of intent with SALT Blockchain, Inc....
August 16, 2023
LexAmgen Inc
Amgen/Horizon: swoop on rare disease specialist will push up debt load Premium content
...The wider S&P Biotech index trades on a multiple of 11.4 times....
December 12, 2022
Live news updates from October 18: Russian missiles hit Kyiv for second day, Goldman Sachs announces overhaul
Stocks extend rally ahead of fresh flurry of US earnings
...Stock markets extended their gains on Tuesday, as the UK’s U-turn on planned tax cuts bolstered sentiment ahead of a fresh batch of Wall Street corporate earnings....
October 18, 2022
Pharmaceuticals sector
Merck in talks over $40bn deal for cancer biotech SeaGen
...SeaGen also recently signed a partnership with French drugmaker Sanofi and has agreements with Takeda and Bristol Myers Squibb among others. SeaGen declined to comment....
July 7, 2022
Television
Everything you don’t actually need to know about the economics of Succession
...Here’s our best attempt at taking a photo of the phone: OK, the Waystar Corp. of S1E3 now seems to be Waystar Royco Inc/WAY:NYSE, which plausibly could be a security representing a different class of shares...
April 21, 2023
National Health Service
Drug companies warn UK over ‘penalising rebate’
...Matthew Eddleston, Celltrion’s commercial and operations director, pointed to the trebling of the rebate it paid to the health service in January 2022 from 5.1 per cent in 2021, and said 2023’s rate was...
October 24, 2022
FirstFT
FirstFT: White House accuses Opec+ of aligning with Russia
...Yesterday, a Danish and two American scientists won the chemistry prize for discovering “click chemistry”, a way of putting molecules together that has transformed pharmaceutical and medical research....
October 6, 2022
FT Asset Management
Asset management: Fallout from the Adani Group
...A modest proposal for Goldman Goldman Sachs partners are meeting in Florida this week after a difficult stretch, with 3,000 lay-offs, falling profits and a big strategy U-turn by chief executive David Solomon...
February 6, 2023
UK public finances
Second rating agency cuts UK outlook in wake of mini-Budget
...The rating agency maintained the UK’s AA- investment grade but warned that the outlook was now negative rather than stable, mirroring the action taken last week by its peer S&P....
October 5, 2022

Previous pagePage 1 of 65Next page